Tolterodine (brand name Detrol, Detrol LA) is a muscarinic receptor antagonist approved for overactive bladder with urge urinary incontinence, urgency, and urinary frequency. It is among the most commonly prescribed OAB medications for California women, often tried after or instead of oxybutynin.
How Tolterodine Differs from Oxybutynin
Like oxybutynin, tolterodine works by blocking muscarinic receptors in the bladder to reduce involuntary contractions. However, tolterodine has somewhat more bladder selectivity than oxybutynin and tends to cause less severe dry mouth in many San Diego patients — though it still carries a similar side effect profile overall.
Effectiveness for OAB
Clinical trials show tolterodine reduces urgency episodes, leakage episodes, and urinary frequency in patients with OAB. The extended-release formulation (Detrol LA) generally provides more consistent symptom relief than the immediate-release version and may be better tolerated.
Side Effects in California Patients
Common side effects of tolterodine include dry mouth (less common than with oxybutynin but still present in 20–40% of patients), constipation, headache, and blurred vision. Like all antimuscarinic OAB medications, tolterodine carries concerns about cognitive effects with long-term use in older California patients.
When Tolterodine Isn't Enough
Many San Diego women start with tolterodine and find partial benefit, inadequate benefit, or side effects that limit use. Documented tolterodine trials — whether stopped due to side effects or insufficient response — contribute to the clinical record that supports insurance authorization for advanced OAB therapy in California.
California Bladder treats San Diego patients who have tried antimuscarinic medications without adequate benefit. Call (858) 571-3630 to discuss next steps including sacral neuromodulation and PTNS at our California locations.
This article is for informational purposes only and does not constitute medical advice. Coverage information is general; individual plan requirements vary. A clinical evaluation is required.